Unlimited PTO has become a popular perk for attracting and retaining talent — but don’t let its simplicity fool you. Beneath the surface lies a web of compliance considerations that vary by state and can create hidden legal risks for well-meaning employers.  Is your unlimited PTO policy putting your organization at risk?  In our latest guide, Compliance Considerations for Unlimited PTO Policies , we unpack the top legal pitfalls like state-mandated leave accrual rules, conflicting payout laws and the nuances of “use-it-or-lose-it” regulations.  [Download the full guide]   From California’s sick leave accrual tracking to Colorado’s payout exemptions, state laws aren’t one-size-fits-all. This resource is essential for any HR leader or compliance officer considering — or already offering — unlimited PTO.  This content is for informational purposes only. It has been partially generated from an AI language model, which may not always be exhaustive or tailored ...

Welcome to the May edition of Benefits Buzz ! In this monthly issue, we dive into the latest topics related to employee benefits, wellness programs and ever-evolving workplace dynamics. Stay informed and gain insights that help you make the most of your benefits package.  This month's highlights  Topic #1: DOL updates model employer CHIP notice.  Topic #2: Prescription Drug (RxDC) report is due by Jun. 1, 2025.   Download the full story  For an in-depth look at this month's topics, download the PDF below. Dive deeper into the advice and guidance that can help you leverage your benefits to their fullest potential. Don't miss out on valuable insights that could improve your professional and personal life.  [Download the Full Story PDF]  Stay informed, stay empowered and make the most of your benefits with Benefits Buzz! Be sure to follow us on LinkedIn for monthly updates and never miss out on the latest in benefits news.  Questions?  If ...

With U.S. healthcare costs projected to rise by up to 8% in 2025, employers are facing a new challenge: how to manage the growing cost of GLP-1 medications like Ozempic®, Wegovy® and Mounjaro®. Originally approved to treat Type 2 diabetes, these drugs are increasingly prescribed for weight loss — and they aren’t cheap.  [Learn more in our Healthcare Cost Spotlight]   GLP-1 considerations for health plans  A Per a Business Group on Health (BGH) survey , new data shows more than half of large employers say GLP-1s are “greatly” driving up health plan costs — and demand is rising fast. With over 100 similar drugs in development and more use cases emerging, from treating obesity to sleep apnea and heart disease, this trend isn’t slowing down anytime soon.  To control costs, employers are exploring options like:  requiring BMI thresholds and prior authorization;  pairing GLP-1 coverage with lifestyle or wellness programs;  adjusting cost-sharing arrangements...

Why proactive communication and accessibility matter more than ever  The conversation around employee mental health is no longer on the sidelines. As burnout, stress and anxiety continue to rise in workplaces nationwide, employers are facing growing pressure to evolve how they support mental health — not just with benefits, but with strategies that boost engagement, access and utilization.  Many organizations offer traditional resources like Employee Assistance Programs (EAPs) and mental health leave. But too often, employees aren’t aware these benefits exist or don’t know how to access them when they need help the most.  That’s why we’re helping you rethink your approach to mental health benefits — with strategies that don’t just support employee well-being but also deliver measurable business impact.  [Get Mental Health Care Benefits Strategies Here]   Want to learn more about mental health offerings?  Let’s talk about how your organization can get more ...

A shaky start amid tariffs and global uncertainty  After two strong years for U.S. markets, 2025 kicked off with turbulence. What began as a promising first quarter ended in market correction territory, driven by rising tariff tensions, softening earnings projections and uncertainty surrounding Federal Reserve policy.   Download our Q1 2025 Market Recap to get the complete overview, including data, charts and more.  [Yes, I Want the Full Breakdown]  Key market highlights from Q1 2025  Equities  Investor sentiment waned throughout the quarter, especially regarding U.S. large-cap stocks. Concerns over new tariffs and earnings downgrades weighed on performance, while non-U.S. markets outperformed their American counterparts.  Fixed income  Bond markets recovered some ground in Q1, offering investors a rare bright spot amid equity market weakness. Traditional safe havens like gold also gained attention during the quarter.  Global markets...